Elron 2005 profits fall

During the year, the Tel Aviv-based holding company its stake in Partner Communications, in Oren Semiconductor and decreased its shares in Internet provider Netvision.

By AVI KRAWITZ
March 16, 2006 07:15

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Elron Electronic Industries Ltd. on Wednesday reported net income of $47.3m., or $1.61 per share for 2005, compared to $84.1m., or $2.87 per share, the previous year. Excluding gains from the divestments, Elron said it would have lost $23m. compared to a net loss of $23.3m in 2004. Revenues dropped 40.73% to $82.6m. from $139.4m. "We completed a number of significant exits resulting in aggregate cash to Elron of approximately $116m.," said president and CEO Doron Birger. During the year, the Tel Aviv-based holding company its stake in Partner Communications, in Oren Semiconductor and decreased its shares in Internet provider Netvision. Elron is divided into four groups with subsidiaries in the medical devices, Telecommunications, Semiconductor and advanced materials sectors.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS